… -label extension portion of this study will provide a foundation regarding the efficacy and
safety of long-term adalimumab therapy in Japanese patients with chronic plaque psoriasis. …

… metastasis in Japanese patients with RCC (6), new therapies are needed to treat advanced
RCC because of the relatively infrequent clinical activity and unsatisfactory safety profile of …

… The low rates of discontinuation in this study and in the OLTP of the Phase 2 study in Japanese
patients 17 are consistent with the observed efficacy and safety findings in this study. The …

… The data presented here pertain to the Japanese patients from ERASURE. … The results
from the Japanese patients also suggest superior efficacy of the secukinumab 300 mg dose …

… efficacy and favorable tolerability observed with G/P in this study were similar to those
observed in Japanese patients … are consistent with studies of G/P conducted outside Japan.(16) …

… a 52-week efficacy and safety trial of adalimumab in anti-TNF–naïve Japanese patients with
… Additionally, this study did not evaluate the efficacy of adalimumab in Japanese patients …

… the efficacy, safety and optimal doses of canagliflozin for the treatment of type 2 diabetes in
Japanese patients. … The results of this study show favourable efficacy and safety profiles of …

… In this study of Japanese patients with type 2 diabetes, treatment with sitagliptin monotherapy
produced statistically significant and clinically important reductions in HbA 1c and fasting …

… In particular, this study was performed in Japanese patients, which may limit generalizability
of the results to other populations. In addition, the study was only 24 weeks long, which …

… the efficacy and safety of sunitinib in Japanese patients with … report the efficacy and safety
results of the first Japanese phase … cytokine-pretreated Japanese patients with metastatic RCC. …